Ned Scheetz is the Founder and Managing Partner of Aphelion Capital, a healthcare venture firm he established in 2005. See contact routes.
Ned Scheetz is the Founder and Managing Partner of Aphelion Capital, a healthcare venture firm he established in 2005, bringing over 20 years of experience that includes a prior eight-year tenure as a partner at Piper Jaffray Ventures focusing on emerging medical technology. His investment thesis targets seed through Series B stages in sectors such as medical devices, health IT, bio-tech, and consumer health, with a geographic focus on the Colorado and Utah regions. Scheetz typically invests between $100,000 and $5 million and is known to lead syndicates up to $20 million or invest solo on smaller seed rounds. Notable portfolio companies include Silk Road Medical, Eargo, Minerva Surgical, and Biolinq, which received a Series E investment from the firm in March 2025. The firm’s distinctive point of view centers on technologies that reduce burdens on the healthcare system and products that treat the patient as the consumer. While Scheetz serves on multiple private company boards including Aardvark Medical and Freespira, the available sources do not cite specific public writing or a unique personal manifesto beyond the firm’s stated strategy.
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to comparable investors.
Investors like Ned Scheetz · Full investor directory · Investor access · Company funding database